Anti- EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.Linvention concerne des anticorps anti-EGFR, des compositions thérapeutiques comprenant des combinaisons danticorps anti-EGFR, ainsi que des procédés dutilisation de ces anticorps et des compositions pour traiter des troubles liés à EGFR (par exemple, cancers).